Drug Trials Snapshots: DUVYZAT
Summary
DUVYZAT is a histone deacetylase inhibitor that is approved for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.
Description
DUVYZAT is a histone deacetylase inhibitor that is approved for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source